Expanding our Outreach
Posted: Monday June 3, 2019
DB-i’s goal of being the acknowledged go-to resource for dense breast education is often supported by professional organizations and health care facilities that provide a direct link to our site.
Welcoming New Educational Supporter and News from DB-i Europe
Posted: Tuesday May 28, 2019
Educational SupportersWELCOME ABOARD! We welcome Hitachi Healthcare to the DenseBreast-info.org Education Coalition of Supporters! Hitachi joins current supporters including: GE Healthcare, Volpara
Research Launch and Patient Brochures
Posted: Monday May 20, 2019
Research Launch: There was strong interest from the radiological press in the research launch news release sent out earlier this week. It was picked up by AuntMinnie, Radiology
FAQ Updates and Hellenic Breast Imaging Meeting
Posted: Monday May 13, 2019
Expanded FAQs for Patients and Providers We’ve recently expanded our FAQs and added 3 new questions: Question #16 in FAQs for Patients – Should I start screening mammography at age 40 or 50?
News About Georgia and FAQ Updates
Posted: Thursday May 9, 2019
Legislation News: Georgia Signs On! Georgia joins the ranks of those states that have breast density inform laws. The state became the 38th to require health care facilities conducting mammograms to
Facebook Milestone and Screening Technology Updates
Posted: Monday May 6, 2019
Facebook 10K and Counting It’s official! DenseBreast-info.org now has over 10,000 Facebook followers. In addition to our website and educational videos, we consider our social networks and
Proposed FDA/MQSA Amendment, Video, DB-i Map Expansion
Posted: Monday April 22, 2019
Proposed MQSA Amendment: Dr. Wendie Berg provided her perspective on the FDA’s proposed MQSA amendment during an interview with Imaging Technology News (ITN) at the SBI conference last week. See
Comparison of Cancer Detected by Ultrasound and 3D Mammography
Posted: Thursday April 4, 2019
An abstract presented at the American Roentgen Ray Society meeting on May 2, 2017 in New Orleans by Dr. Stamatia Destounis. Researchers at Elizabeth Wende Breast Care in Rochester, New York,
ASTOUND-2 Study
Posted: Thursday April 4, 2019
ASTOUND-2 [1] is a large, prospective multicentre trial in Italy that directly compares the incremental cancer detection and “false positive” (false alarm) recall rates for ultrasound (sonogram)
FDA Proposes New Mammography Regulations
Posted: Thursday April 4, 2019
From the FDA: For the first time in more than 20 years of regulating mammography facilities, the FDA has announced important new steps to modernize breast cancer screening and help empower
FDA MQSA and DBI Europe Updates
Posted: Saturday January 19, 2019
FDA Proposed Rule on Mammography Quality Standards Act (MQSA): It’s done! After multiple iterations and a great deal of useful input from many of you, DBI has submitted its comments to the FDA on
Why Screening Before Age 45 Matters
Posted: Tuesday January 15, 2019
DO I NEED A MAMMOGRAM BEFORE I TURN 45? YES. The entire reason we screen for breast cancer is to find it EARLY, when most treatable and survivable. Breast cancer is the number one cause of death in
Screening in Women at Higher Than Average Risk
Posted: Wednesday March 7, 2018
The American College of Radiology (ACR [1]) recommends all women, and especially black women and those of Ashkenazi Jewish descent, should undergo risk assessment by age 30 so that women at higher
Research Study in Western Pennsylvania
Posted: Saturday January 7, 2017
A trial evaluating screening ultrasound after tomosynthesis (3D mammography) is ongoing at the University of Pittsburgh School of Medicine/UPMC. The study is funded by the National Cancer Institute
ASTOUND Study
Posted: Tuesday January 3, 2017
ASTOUND is the first published prospective multicenter trial to directly compare cancer detection and “false positive” (false alarm) rates of ultrasound (sonogram) and tomosynthesis (a form of 3D